Elisa Wistorf

Elisa Wistorf

Auto-generated profile, based on publicly available information

Elisa Wistorf

German Federal Institute for Risk Assessment, German Centre for the Protection of Laboratory Animals (Bf3R), 10589 Berlin, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
AMAndrás Maifeld
András Maifeld
Johannes WildJohannes Wild
Johannes Wild
TKTine V. Karlsen
Tine V. Karlsen
NRNatalia Rakova
Natalia Rakova
EWElisa Wistorf
Elisa Wistorf
LMLajos Marko
Lajos Marko

16 November 2022 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
MBMiriam Bühler
Miriam Bühler
JFJeanine Fahrländer
Jeanine Fahrländer
ASAlexander Sauter
Alexander Sauter
MBMarkus Becker
Markus Becker
EWElisa Wistorf
Elisa Wistorf
ASAline Stolz
Aline Stolz
The role of the alternate G protein–coupled estrogen receptor 1 (GPER1) in colorectal cancer (CRC) development and progression is unclear, not least because of conflicting clinical and experimental evidence for pro- and anti-tumorigenic activities. Here, we show that low concentrations of the estrogenic GPER1 ligands, 17β-estradiol, bisphenol A, and diethylstilbestrol cause the generation of lagging chromosomes in normal colon and CRC cell lines, which manifest in whole chromosomal instability and aneuploidy. Mechanistically, (xeno)estrogens triggered centrosome amplification by inducing centriole overduplication that leads to transient multipolar mitotic spindles, chromosome alignment defects, and mitotic laggards. Remarkably, we could demonstrate a significant role of estrogen-activated GPER1 in centrosome amplification and increased karyotype variability. Indeed, both gene-specific knockdown and inhibition of GPER1 effectively restored normal centrosome numbers and karyotype stability in cells exposed to 17β-estradiol, bisphenol A, or diethylstilbestrol. Thus, our results reveal a novel link between estrogen-activated GPER1 and the induction of key CRC-prone lesions, supporting a pivotal role of the alternate estrogen receptor in colon neoplastic transformation and tumor progression.

3 July 2023 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
JSJulia Scheinpflug
Julia Scheinpflug
CHChris Tina Höfer
Chris Tina Höfer
SSSarah S. Schmerbeck
Sarah S. Schmerbeck
MSMatthias Steinfath
Matthias Steinfath
JDJennifer Doka
Jennifer Doka
FSFrank Schulze
Frank Schulze
Throughout life, continuous remodelling is part of human bone biology and depends on the simultaneous action of physicochemical parameters such as oxygen tension and varying mechanical load. Thus, suitable model systems are needed, which allow concomitant modulation of these factors to recapitulate in vivo bone formation. Here, we report on the development of a first microphysiological system (MPS) that enables perfusion, environment-independent regulation of the oxygen tension as well as precise quantification and control of mechanical load. To demonstrate the use of the MPS for future studies on the (patho-)biology of bone, we built a simplified 3D model for early de novo bone formation. Primary human osteoblasts (OBs), which are the key players during this process, were seeded onto type I collagen scaffolds and cultured in the MPS. We could not only monitor cell viability and metabolism of OBs under varied physicochemical conditions, but also visualise the mineralisation of the extracellular matrix. In summary, we present a MPS that uniquely combines the independent control of physicochemical parameters and allows investigation of their influence on bone biology. We consider our MPS highly valuable to gain deeper insights into (patho-)physiological processes of bone formation in the future.